Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet

World Journal of Gastroenterology

Volumn 11, Issue 42, 2005, Pages 6671-6675

  Bene, Judit ^a,b   Komlósi, Katalin ^a   Gasztonyi, Beáta ^a   Juhász, Márk ^c   Tulassay, Zsolt ^c   Melegh, Béla ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Celiac disease; Plasma carnitine ester profile

Indexed keywords

ACETYLCARNITINE; ALKYL GROUP; BUTYRYLCARNITINE; CARNITINE; CARNITINE DERIVATIVE; CARNITINE ESTER; CECENOYLCARNITINE; DECANOYLCARNITINE; ESTER; ESTER DERIVATIVE; HEXANOYLCARNITINE; LAUROYLCARNITINE; MYRISTOLEYLCARNITINE; MYRISTOYLCARNITINE; OCTANOYLCARNITINE; OCTENOYLCARNITINE; OLEYLCARNITINE; PROPIONYLCARNITINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD LEVEL; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; LONG TERM CARE; MALE; QUADRUPOLE MASS SPECTROMETRY;

EID: 30444447247     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i42.6671     Document Type: Article

References (43)

1. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383-391
2. Shamir R. Advances in celiac disease. Gastroenterol Clin North Am 2003; 32: 931-947
3. Capristo E, Addolorato G, Mingrone G, De Gaetano A, Greco AV, Tataranni PA, Gasbarrini G. Changes in body composition, substrate oxidation, and resting metabolic rate in adult celiac disease patients after a 1-y gluten-free diet treatment. Am J Clin Nutr 2000; 72: 76-81
4. Capristo E, Addolorato G, Mingrone G, Scarfone A, Greco AV, Gasbarrini G. Low-serum high-density lipoprotein-cholesterol concentration as a sign of celiac disease. Am J Gastroenterol 2000; 95: 3331-3332
5. Vuoristo M, Kesaniemi YA, Gylling H, Miettinen TA. Metabolism of cholesterol and apolipoprotein B in celiac disease. Metabolism 1993; 42: 1386-1391
6. Ciampolini M, Bini S. Serum lipids in celiac children. J Pediatr Gastroenterol Nutr 1991; 12: 459-460
7. Rosenthal E, Hoffman R, Aviram M, Benderly A, Erde P, Brook JG. Serum lipoprotein profile in children with celiac disease. J Pediatr Gastroenterol Nutr 1990; 11: 58-62
8. Bieber LL. Carnitine. Annu Rev Biochem 1988; 57: 261-283
9. Melegh B, Kerner J, Bieber LL. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol 1987; 36: 3405-3409
10. Kerner J, Hoppel C. Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr 1998; 18: 179-206
11. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429
12. Melegh B, Hermann R, Bock I. Generation of hydroxytrimethyllysine from trimethyllysine limits the carnitine biosynthesis in premature infants. Acta Paediatr 1996; 85: 345-350
13. Vaz FM, Melegh B, Bene J, Cuebas D, Gage DA, Bootsma A, Vreken P, van Gennip AH, Bieber LL, Wanders RJ. Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry. Clin Chem 2002; 48: 826-834
14. Hamilton JW, Li BU, Shug AL, Olsen WA. Carnitine transport in human intestinal biopsy specimens. Demonstration of an active transport system. Gastroenterology 1986; 91: 10-16
15. McCloud E, Ma TY, Grant KE, Mathis RK, Said HM. Uptake of L-carnitine by a human intestinal epithelial cell line, Caco-2. Gastroenterology 1996; 111: 1534-1540
16. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-1194
17. Costa CC, de Almeida IT, Jakobs C, Poll-The BT, Duran M. Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res 1999; 46: 440-444
18. Vreken P, van Lint AE, Bootsma AH, Overmars H, Wanders RJ, van Gennip AH. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects. J Inherit Metab Dis 1999; 22: 302-306
19. Stahlberg MR, Savilahti E, Siimes MA. Iron deficiency in coeliac disease is mild and it is detected and corrected by gluten-free diet. Acta Paediatr Scand 1991; 80: 190-193
20. Sategna Guidetti C, Scaglione N, Martini S. Red cell distribution width as a marker of coeliac disease: a prospective study. Eur J Gastroenterol Hepatol 2002; 14: 177-181
21. Dickey W, Bodkin S. Prospective study of body mass index in patients with coeliac disease. BMJ 1998; 317: 1290
22. Mody RJ, Brown PI, Wechsler DS. Refractory iron deficiency anemia as the primary clinical manifestation of celiac disease. J Pediatr Hematol Oncol 2003; 25: 169-172
23. Hjelt K, Krasilnikoff PA. The impact of gluten on haematological status, dietary intakes of haemopoietic nutrients and vitamin B12 and folic acid absorption in children with coeliac disease. Acta Paediatr Scand 1990; 79: 911-919
24. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003; 49: 1797-1817
25. Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003; 111: 1399-1406
26. Li B, Lloyd ML, Gudjonsson H, Shug AL, Olsen WA. The effect of enteral carnitine administration in humans. Am J Clin Nutr 1992; 55: 838-845
27. Baker H, Frank O, DeAngelis B, Baker ER. Absorption and excretion of L-carnitine during single or multiple dosings in humans. Int J Vitam Nutr Res 1993; 63: 22-26
28. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998; 273: 20378-20382
29. Zaspel BJ,, Sheridan KJ, Henderson LM. Transport and metabolism of carnitine precursors in various organs of the rat. Biochim Biophys Acta 1980; 631: 192-202
30. Green PH, Glickman RM. Intestinal lipoprotein metabolism. J Lipid Res 1981; 22: 1153-1173
31. Field FJ, Mathur SN. Intestinal lipoprotein synthesis and secretion. Prog Lipid Res 1995; 34: 185-198
32. Cartwright IJ, Higgins JA. Molecular and intracellular events in the assembly and secretion of chylomicrons by enterocytes. Biochem Soc Trans 1998; 26: 211-216
33. Raybould HE. Nutrient tasting and signaling mechanisms in the gut. I. Sensing of lipid by the intestinal mucosa. Am J Physiol 1999; 277: G751-G755
34. Tso P, Nauli A, Lo CM. Enterocyte fatty acid uptake and intestinal fatty acid-binding protein. Biochem Soc Trans 2004; 32: 75-78
35. Mediene S, Hakem S, Bard JM, Medjaoui I, Benhamamouch S, Lebel P, Fruchart JC, Clavey V. Serum lipoprotein profile in Algerian patients with celiac disease. Clin Chim Acta 1995; 235: 189-196
36. Pillan MN, Spandrio S, Sleiman I, Meini A, Scalvini T, Balestrieri GP. Effects of a gluten-free diet on serum lipids and lipoprotein (a) levels in a group of patients with celiac disease. J Pediatr Gastroenterol Nutr 1994; 18: 183-185
37. Sandor A, Kispal G, Melegh B, Alkonyi I. Ester composition of carnitine in the perfusate of liver and in the plasma of donor rats. Eur J Biochem 1987; 170: 443-445
38. Lerner A, Gruener N, Iancu TC. Serum carnitine concentrations in coeliac disease. Gut 1993; 34: 933-935
39. Fitzgerald JF, Troncone R, Roggero P, Pozzi E, Garavaglia B, Parini R, Carissimi E, Santus F, Piemontese P, Cataliotti E, Mosca F, Carnelli V. Clinical quiz. Secondary carnitine deficiency due to celiac disease. J Pediatr Gastroenterol Nutr 2003; 36: 636, 646
40. Hardoff D, Sharf B, Berger A. Myopathy as a presentation of coeliac disease. Dev Med Child Neurol 1980; 22: 781-783
41. Rossi T. Celiac disease. Adolesc Med Clin 2004; 15: 91-103
42. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003; 41: S4-12
43. Abdulkarim AS, Murray JA. Review article: The diagnosis of coeliac disease. Aliment Pharmacol Ther 2003; 17: 987-995